Progate Group Corporation (TPEX:8227)

Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	795.89	921.57	565.87	522.07	186.4	62.87
Trading Asset Securities	127.27	126.04	33.28	42.8	45.74	60.04
Cash & Short-Term Investments	923.16	1,048	599.15	564.87	232.13	122.91
Cash Growth	29.12%	74.85%	6.07%	143.34%	88.87%	-8.88%
Accounts Receivable	216.65	73.53	152.89	65.58	53.82	34.46
Other Receivables	3.9	2.73	11.68	7.5	0.06	3.89
Receivables	220.55	76.26	164.57	73.08	53.88	38.35
Inventory	67.28	69.95	106.17	165.94	68.01	98.38
Prepaid Expenses	244.46	0.73	9.1	9.06	8.29	7.66
Other Current Assets	24.18	23.33	62.84	23.92	25.49	3.29
Total Current Assets	1,480	1,218	941.81	836.87	387.8	270.58
Property, Plant & Equipment	123.97	125.35	123.42	120.13	120.67	121.25
Other Intangible Assets	80.64	102.96	0.23	-	-	-
Long-Term Deferred Tax Assets	18.6	12.45	14.96	15.89	8.21	15.46
Other Long-Term Assets	10.13	3.53	2.91	1.94	1.94	2.33
Total Assets	1,713	1,462	1,083	974.82	518.61	409.61
Accounts Payable	18.49	49.73	80.09	61.36	41.62	31.12
Accrued Expenses	-	70.74	33.86	26.01	17.5	15.75
Current Portion of Leases	1.79	1.01	0.93	0.77	1.06	1.11
Current Income Taxes Payable	11.42	2.25	29.28	23.96	0.64	-
Current Unearned Revenue	467.98	153.9	123.46	140.21	106.53	69.2
Other Current Liabilities	126.59	1.79	2.14	7.21	3.03	1.35
Total Current Liabilities	626.27	279.42	269.75	259.52	170.36	118.53
Long-Term Leases	1.38	1.39	0.94	0.6	1.44	1.12
Long-Term Unearned Revenue	-	-	-	-	-	0.66
Long-Term Deferred Tax Liabilities	-	3.44	-	3.31	0.73	0.63
Other Long-Term Liabilities	21.26	46.23	-	-	0.77	0.77
Total Liabilities	648.9	340.06	284.73	279.9	194.85	144.01
Common Stock	395.43	395.43	373.43	373.43	331.93	331.93
Additional Paid-In Capital	575.07	575.07	253.21	253.21	0.12	-
Retained Earnings	93.57	151.6	171.97	68.29	-8.29	-66.33
Shareholders' Equity	1,064	1,122	798.61	694.93	323.76	265.6
Total Liabilities & Equity	1,713	1,462	1,083	974.82	518.61	409.61
Total Debt	3.16	2.4	1.87	1.37	2.49	2.23
Net Cash (Debt)	920	1,045	597.28	563.49	229.64	120.68
Net Cash Growth	29.32%	75.00%	6.00%	145.38%	90.29%	-9.02%
Net Cash Per Share	23.29	27.46	15.98	16.87	6.92	3.64
Filing Date Shares Outstanding	38.58	39.54	37.34	37.34	33.19	33.19
Total Common Shares Outstanding	38.58	39.54	37.34	37.34	33.19	33.19
Working Capital	853.37	938.45	672.06	577.35	217.44	152.06
Book Value Per Share	27.58	28.38	21.39	18.61	9.75	8.00
Tangible Book Value	983.43	1,019	798.38	694.93	323.76	265.6
Tangible Book Value Per Share	25.49	25.77	21.38	18.61	9.75	8.00
Land	-	85.77	85.77	85.77	85.77	85.77
Buildings	-	50.63	49.97	49.61	49.51	49.51
Machinery	-	13.47	10.21	5.85	8.28	14.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.